Skip to main content

Articles

Review Article, Pulmonary, Original Research

The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes

David L. Larsen, RN, MHA; Hitesh Gandhi, MBBS; Michael Pollack, MS; Norbert Feigler, MD; Sushma Patel, PharmD; Robert A. Wise, MD

GU Cancers Symposium Highlights

Neoadjuvant Enfortumab Vedotin Therapy Promising in Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin

GU Cancers Symposium Highlights

Continuous Treatment with Enzalutamide and Docetaxel Reduces the Risk for Progression in Patients with Metastatic Castration-Resistant Prostate Cancer

GU Cancers Symposium Highlights

Darolutamide plus ADT and Docetaxel Improves Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer

Interview with the Innovators

Genmab Is Ready to Enter the US Market to Help Improve the Lives of People with Cancer

Opdivo plus Platinum-Based Chemotherapy FDA Approved as First Neoadjuvant Treatment in Early-Stage NSCLC

Lynparza Receives FDA Approval for Adjuvant Treatment of High-Risk Early Breast Cancer with BRCA Mutation

Keytruda Monotherapy FDA Approved for Endometrial Carcinoma with a Biomarker

Carvykti Second BCMA-Directed CAR T-Cell Therapy FDA Approved for Multiple Myeloma

Opdualag, a Novel Immunotherapy Combination, FDA Approved for Advanced Melanoma

Page 16 of 244
Results 151 - 160 of 2440